A look at the numbers: 19/90 patients had REBOA in the UK-REBOA Trial 16 Trial Sites 25 authors As you read through my proposed additions
Disclaimer: As an academic vascular surgeon having run and participated in multiple randomized controlled trials in the past, this commentary is not meant to devalue the
It’s been just over 2 years since we published our first COBRA-OS® study, “Size Matters; first-in-human study of a novel 4 French REBOA device.” Since that study,
Dr. Adam Power, our co-founder and CMO discussed REBOA complications, training and technology at the 5th World Coalition for Trauma Care Virtual Conference.
First-in-Human Study of a Novel 4 French REBOA Device
Simplifying Aortic Occlusion for Better Patient Care